Evidence map›Paper›PMID 35622882›Full record

ArticlePLoS genetics2022

Production of 3',3'-cGAMP by a Bdellovibrio bacteriovorus promiscuous GGDEF enzyme, Bd0367, regulates exit from prey by gliding motility.

Rebecca C Lowry, Zachary F Hallberg, Rob Till, Tyler J Simons, Ruth Nottingham, Fiona Want, R Elizabeth Sockett, Ming C Hammond, Carey Lambert

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Rebecca C LowrySchool of Life Sciences, University of Nottingham, Medical School, Nottingham, United Kingdom.ORCID 0000-0003-0375-8522
Zachary F HallbergUniversity of California, Berkeley, Department of Chemistry, Berkeley, California, United States of America.ORCID 0000-0001-7732-2073
Rob TillSchool of Life Sciences, University of Nottingham, Medical School, Nottingham, United Kingdom.
Tyler J SimonsUniversity of Utah, Department of Chemistry and Center for Cell & Genome Science, Salt Lake City, Utah, United States of America.ORCID 0000-0002-0150-9947
Ruth NottinghamSchool of Life Sciences, University of Nottingham, Medical School, Nottingham, United Kingdom.
Fiona WantSchool of Life Sciences, University of Nottingham, Medical School, Nottingham, United Kingdom.
R Elizabeth SockettSchool of Life Sciences, University of Nottingham, Medical School, Nottingham, United Kingdom.ORCID 0000-0002-6271-2674
Ming C HammondUniversity of Utah, Department of Chemistry and Center for Cell & Genome Science, Salt Lake City, Utah, United States of America.ORCID 0000-0003-2666-4764
Carey LambertSchool of Life Sciences, University of Nottingham, Medical School, Nottingham, United Kingdom.ORCID 0000-0002-1844-457X
University of Nottingham · GBUniversity of Utah · USUniversity of California, Berkeley · US

Funding

Enabling High-Throughput Analysis and Single-Cell Imaging of Bacterial SignalsR01GM124589 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI HAMMOND, MING CHEN · 2017 to 2025
$2.8M
Biotechnology and Biological Sciences Research Council BB/M010325/1NIGMS NIH HHS R01 GM124589
6 · The paper itself

Abstract

Bacterial second messengers are important for regulating diverse bacterial lifestyles. Cyclic di-GMP (c-di-GMP) is produced by diguanylate cyclase enzymes, named GGDEF proteins, which are widespread across bacteria. Recently, hybrid promiscuous (Hypr) GGDEF proteins have been described in some bacteria, which produce both c-di-GMP and a more recently identified bacterial second messenger, 3',3'-cyclic-GMP-AMP (cGAMP). One of these proteins was found in the predatory Bdellovibrio bacteriovorus, Bd0367. The bd0367 GGDEF gene deletion strain was found to enter prey cells, but was incapable of leaving exhausted prey remnants via gliding motility on a solid surface once predator cell division was complete. However, it was unclear which signal regulated this process. We show that cGAMP signalling is active within B. bacteriovorus and that, in addition to producing c-di-GMP and some c-di-AMP, Bd0367 is a primary producer of cGAMP in vivo. Site-directed mutagenesis of serine 214 to an aspartate rendered Bd0367 into primarily a c-di-GMP synthase. B. bacteriovorus strain bd0367S214D phenocopies the bd0367 deletion strain by being unable to glide on a solid surface, leading to an inability of new progeny to exit from prey cells post-replication. Thus, this process is regulated by cGAMP. Deletion of bd0367 was also found to be incompatible with wild-type flagellar biogenesis, as a result of an acquired mutation in flagellin chaperone gene homologue fliS, implicating c-di-GMP in regulation of swimming motility. Thus the single Bd0367 enzyme produces two secondary messengers by action of the same GGDEF domain, the first reported example of a synthase that regulates multiple second messengers in vivo. Unlike roles of these signalling molecules in other bacteria, these signal to two separate motility systems, gliding and flagellar, which are essential for completion of the bacterial predation cycle and prey exit by B. bacteriovorus.

Indexed as

Bdellovibrio bacteriovorusBacterial ProteinsNucleotides, CyclicBacterial Proteinscyclic guanosine monophosphate-adenosine monophosphateNucleotides, Cyclic

Identifiers

PMID35622882
PMCPMC9140294
OpenAlexW4281695741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.